发明名称 |
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Paget's Disease of Bone |
摘要 |
Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailabillty of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form |
申请公布号 |
US2016158255(A1) |
申请公布日期 |
2016.06.09 |
申请号 |
US201615043141 |
申请日期 |
2016.02.12 |
申请人 |
Antecip Bioventures II LLC |
发明人 |
Tabuteau Herriot |
分类号 |
A61K31/675;A61K9/20;A61K9/00 |
主分类号 |
A61K31/675 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating Paget's disease of bone, comprising orally administering zoledronic acid in a disodium salt form to a mammal in need thereof, wherein the zoledronic acid in the disodium salt form is administered in an amount and frequency that results in an AUC of zoledronic acid, over a four week period, that is about 100 ng·h/mL to about 2000 ng·h/mL. |
地址 |
New York NY US |